The study demonstrated that the knockdown of TRIM8 via the CRISPR/Cas9 gene editing technique significantly diminished the proliferative capacity and augmented apoptosis in Ewing sarcoma cells. This evidence concerns the gene TRIM8 and Ewing sarcoma.